• The burden of cervical cancer. CME newsletter prepared September 2006. [FR, writer]

• Treating allergic rhinitis and comorbid asthma during pregnancy. Review prepared July 2005. [FR, collaborating writer]

• Wiesenfeld-Hallin Z. Sex differences in pain perception. Gender Med. 2005;2:137-145. [FR, collaborating writer]

• Meeting report, national breast cancer advisory board, prepared June 2005. [FR, writer]

• Taylor D. The science of perimenstrual symptoms and syndromes. Adv Stud Med. 2005;5:228-241. [BAC and FR, collaborating writers]

• Caley BA and Reidenbach F. Making love — and loving it. In: Family Doctor: Your Essential Guide to Health and Wellbeing. Leawood, KS: American Academy of Family Physicians; 2005:180-181.

• Caley BA and Reidenbach F. Expanding options for advanced breast cancer. CURE: Cancer Updates, Research and Education. 2003;2(3):47-53.

• Reidenbach F. Gabapentin may relieve tamoxifen-related hot flushes. Lancet Oncol. 2002;3:393.

• Reidenbach F. Chemotherapy safe in pregnancy. Lancet Oncol. 2002;3:128.

• Reidenbach F. Conceiving solutions: Fertility and cancer treatment. CURE: Cancer Updates, Research and Education. 2002;1(4):22-26.

• Reidenbach F. Boosting immunity to cancer through nutrition. Women’s Health Advisor. 1998;2(1):7.

• Gidwani GP. A History of the Cleveland Society of Obstetricians and Gynecologists, 1947 to 1997. Cleveland, Ohio: Cleveland Clinic Foundation, 1997. [FR, collaborating writer]

• Legato MJ, Padus E, Slaughter E. Women’s perceptions of their general health, with special reference to their risk of coronary artery disease: results of a national telephone survey. J Women’s Health. 1997;6:189-198. [FR, collaborating writer]

• Van Horn C and Barrett P. Pregnancy, delivery and post-partum experience of 54 women with ostomies. J Wound Ostomy Continence Nurses Soc. 1997;24:151-162. [FR, substantive editor]

Bylined news reports distributed on Reuters Health wire service [FR, writer]:

• Active HPV-16 infection relatively uncommon in HIV-infected women in US, 1-27-2003.

• Dextrin sulfate safe and acceptable as a vaginal microbicide, 12-12-2002.

• HPV-positive women with normal Pap at substantial risk of future abnormal Pap, 12-6-2002.

• Novel predictor of breast cancer survival called the most powerful to date, 11-14-2002.

• Central GABA function altered in women with premenstrual dysphoric disorder, 10-2-2002.

• New method of preimplantation genetic diagnosis analyzes every chromosome, 10-1-2002.

• Steroid reduces incidence of ovarian hyperstimulation in women at high risk, 9-27-2002.

• Genetic factors account for most of the population variation in breast density, 9-19-2002.

• Microarray technology may lead to improved assay for fetal Down syndrome, 9-5-2002.

• Prenatal phenobarbital does not enhance infant neurodevelopment, 8-13-2002.

• Public funding of Pap tests linked to lower rate of invasive cervical cancer, 7-5-2002.

• Cardiac autonomic function better with combination HRT than estrogen alone, 6-19-2002.

• Anthracycline/taxane neoadjuvant chemotherapy advised for breast cancer, 4-9-2002.

• Endogenous testosterone may protect postmenopausal women from CVD, 3-14-2002.

• Women might have better HAART outcomes than men, 3-13-2002.

• Clues to why breast cancer more fatal in blacks, 2-7-2002.

• Postmastectomy radiation may be warranted after response to chemotherapy, 1-30-2002.

• Dad’s genes may affect risk of problem pregnancy, 1-7-2002.

• HRT recommended with Gn-RH agonist treatment of endometriosis, 7-5-1999.

• Estrogen-androgen therapy alters body composition in postmenopausal women, 6-23-1999.

• Half-dose HRT regimen controls menopausal symptoms with less bleeding, 5-21-1999.

• ACOG encourages ready access to emergency contraception, 5-19-1999.

• Enhanced Pap testing cost effective for infrequent screening, 1-27-1999.

• Newer Pap tests cost effective, 1-26-1999.

• Anesthetics do not appear to affect success of gamete intrafallopian transfer, 1-11-1999.

• Risk of C-section no higher after epidural, 12-22-1998

• Women can contract HPV from sex with women, 12-21-1998.

• Estrogen replacement reduces plasma viscosity in postmenopausal women, 12-11-1998.

• Incident breast lesions found on MRI unlikely to be malignant, 12-2-1998.

• Adjuvant chemotherapy prolongs survival in high-risk node-negative breast cancer, 10-30-1998.

• Pregnant women develop anti-adhesion antibodies to malaria, 10-29-1998.

• No added cardiovascular disease risk from newer oral contraceptives, 10-9-1998.

• Laparoscopy called “procedure of choice” for reversal of tubal sterilization, 10-7-1998.

• Parathyroid hormone prevents bone loss, 9-22-1998.

• Estrogen replacement therapy benefits postmenopausal women with CHD, 8-27-1998.

• Blood test may screen for ovarian cancer, 8-25-1998.

• HRT does not cut heart risk in heart patients, 8-18-1998.

• Low-dose combination OCs safe after gestational diabetes, 8-12-1998.

• Mifepristone-misoprostol abortion highly acceptable to US women, 7-15-1998.

• More genetic links to breast cancer, 3-31-1998.

• Aspirin does not prevent preeclampsia, 3-11-1998.
   

Home • Bev Caley • Faith Reidenbach • Services • What We've Written • Client Experience • What Our Clients Say

Send mail to Bev@caleyreidenbach.com with questions or comments about this web site.
Last modified: 07/25/07